GUJ.THEMIS. | DENIS CHEM LAB | GUJ.THEMIS./ DENIS CHEM LAB |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 67.8 | 19.1 | 354.1% | View Chart |
P/BV | x | 17.7 | 2.7 | 645.6% | View Chart |
Dividend Yield | % | 0.3 | 1.6 | 19.4% |
GUJ.THEMIS. DENIS CHEM LAB |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
GUJ.THEMIS. Mar-24 |
DENIS CHEM LAB Mar-24 |
GUJ.THEMIS./ DENIS CHEM LAB |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,069 | 160 | 669.0% | |
Low | Rs | 162 | 65 | 249.6% | |
Sales per share (Unadj.) | Rs | 23.4 | 120.9 | 19.3% | |
Earnings per share (Unadj.) | Rs | 8.1 | 8.0 | 101.3% | |
Cash flow per share (Unadj.) | Rs | 8.6 | 13.0 | 66.2% | |
Dividends per share (Unadj.) | Rs | 1.00 | 2.50 | 40.0% | |
Avg Dividend yield | % | 0.2 | 2.2 | 7.3% | |
Book value per share (Unadj.) | Rs | 27.7 | 57.9 | 47.9% | |
Shares outstanding (eoy) | m | 72.64 | 13.88 | 523.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 26.3 | 0.9 | 2,833.3% | |
Avg P/E ratio | x | 75.6 | 14.0 | 540.6% | |
P/CF ratio (eoy) | x | 71.3 | 8.6 | 827.7% | |
Price / Book Value ratio | x | 22.2 | 1.9 | 1,144.2% | |
Dividend payout | % | 12.3 | 31.1 | 39.5% | |
Avg Mkt Cap | Rs m | 44,723 | 1,560 | 2,867.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 102 | 144 | 71.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,698 | 1,678 | 101.2% | |
Other income | Rs m | 44 | 14 | 314.6% | |
Total revenues | Rs m | 1,742 | 1,692 | 102.9% | |
Gross profit | Rs m | 787 | 212 | 370.8% | |
Depreciation | Rs m | 35 | 69 | 50.9% | |
Interest | Rs m | 2 | 5 | 42.2% | |
Profit before tax | Rs m | 793 | 151 | 524.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 202 | 40 | 507.3% | |
Profit after tax | Rs m | 592 | 112 | 530.3% | |
Gross profit margin | % | 46.4 | 12.7 | 366.4% | |
Effective tax rate | % | 25.4 | 26.3 | 96.8% | |
Net profit margin | % | 34.8 | 6.6 | 524.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 676 | 694 | 97.4% | |
Current liabilities | Rs m | 362 | 272 | 133.1% | |
Net working cap to sales | % | 18.5 | 25.1 | 73.6% | |
Current ratio | x | 1.9 | 2.6 | 73.2% | |
Inventory Days | Days | 95 | 5 | 2,052.8% | |
Debtors Days | Days | 581 | 689 | 84.4% | |
Net fixed assets | Rs m | 1,736 | 400 | 434.1% | |
Share capital | Rs m | 73 | 139 | 52.3% | |
"Free" reserves | Rs m | 1,941 | 665 | 291.9% | |
Net worth | Rs m | 2,014 | 804 | 250.6% | |
Long term debt | Rs m | 0 | 5 | 0.0% | |
Total assets | Rs m | 2,412 | 1,093 | 220.5% | |
Interest coverage | x | 347.4 | 28.9 | 1,203.6% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.7 | 1.5 | 45.9% | |
Return on assets | % | 24.6 | 10.7 | 230.2% | |
Return on equity | % | 29.4 | 13.9 | 211.7% | |
Return on capital | % | 39.5 | 19.4 | 203.7% | |
Exports to sales | % | 0 | 2.1 | 0.0% | |
Imports to sales | % | 1.9 | 0 | - | |
Exports (fob) | Rs m | NA | 36 | 0.0% | |
Imports (cif) | Rs m | 33 | NA | - | |
Fx inflow | Rs m | 0 | 36 | 0.0% | |
Fx outflow | Rs m | 33 | 0 | - | |
Net fx | Rs m | -33 | 36 | -90.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 642 | 176 | 364.8% | |
From Investments | Rs m | -552 | -147 | 376.0% | |
From Financial Activity | Rs m | -86 | -42 | 204.2% | |
Net Cashflow | Rs m | 4 | -13 | -32.2% |
Indian Promoters | % | 70.9 | 39.0 | 181.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 2.7 | 0.0 | - | |
FIIs | % | 1.5 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.1 | 61.0 | 47.8% | |
Shareholders | 31,271 | 6,857 | 456.0% | ||
Pledged promoter(s) holding | % | 3.3 | 0.0 | - |
Compare GUJ.THEMIS. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | GUJ.THEMIS. | DENIS CHEM LAB | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 7.60% | 0.66% | 0.67% |
1-Month | 5.04% | -2.45% | -3.33% |
1-Year | 170.31% | 30.07% | 43.33% |
3-Year CAGR | -2.19% | 35.11% | 19.82% |
5-Year CAGR | 57.30% | 37.11% | 26.27% |
* Compound Annual Growth Rate
Here are more details on the GUJ.THEMIS. share price and the DENIS CHEM LAB share price.
Moving on to shareholding structures...
The promoters of GUJ.THEMIS. hold a 70.9% stake in the company. In case of DENIS CHEM LAB the stake stands at 39.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GUJ.THEMIS. and the shareholding pattern of DENIS CHEM LAB.
Finally, a word on dividends...
In the most recent financial year, GUJ.THEMIS. paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 12.3%.
DENIS CHEM LAB paid Rs 2.5, and its dividend payout ratio stood at 31.1%.
You may visit here to review the dividend history of GUJ.THEMIS., and the dividend history of DENIS CHEM LAB.
For a sector overview, read our pharmaceuticals sector report.
On Tuesday, Indian share markets traded on a positive note throughout the session and ended marginally higher.